Vitex Pharmaceuticals

vitexpharma.com

Vitex Pharmaceuticals is a global leader in the contract manufacture of complementary medicine. From our state-of-the-art 26,000sqm best-in-class facility in Sydney, Australia, we are fully equipped to formulate, manufacture and package a wide variety of vitamins, minerals, herbal and nutritional supplements including tablets, softgel capsules, two-piece hardgel capsules and powders.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

CPHI PARTNERS WITH INFORMA PHARMA INTELLIGENCE TO PRESENT THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO IN THE NATIONAL CAPITAL REGION ( NCR)

Informa Pharma Intelligence | November 26, 2021

news image

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, is pleased to announce the 2021 hybrid edition of CPhI – P-MEC conducted by CPhI Conference. The Online Conference & Networking is being held between 15th to 30th Nov 2021, while the In-Person event is being held between 24th to 26th Nov 2021 at India Expo Centre– Greater Noida, Delhi. In a bid to stay afloat towards increasing contemporary demand towards high qu...

Read More

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

Fiercepharma | June 03, 2020

news image

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More

Business Insights

HEALTH CANADA APPROVES IPSEN’S SOHONOS™ (PALOVAROTENE CAPSULES) AS THE FIRST APPROVED TREATMENT FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Ipsen | January 24, 2022

news image

Ipsen announced the Health Canada approval of Sohonos, an oral selective retinoic-acid receptor gamma agonist indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva.1 Sohonos is approved for the treatment of patients with FOP for both chronic use, and for flare-ups, in these patient populations. This decision marks the first approval for Sohonos worldwide.<...

Read More

COVID-19 BRINGS DIVISIONS ON HYDROXYCHLOROQUINE, REOPENING

Fiercepharma | May 19, 2020

news image

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. As the pandemic plays out, political divisions have unfolded around hydroxychloroquine and reopening economies, for starters. At center stage last week was a House hearing over ousted Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright’s whistleblower complaint. While...

Read More
news image

Pharma Tech

CPHI PARTNERS WITH INFORMA PHARMA INTELLIGENCE TO PRESENT THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO IN THE NATIONAL CAPITAL REGION ( NCR)

Informa Pharma Intelligence | November 26, 2021

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, is pleased to announce the 2021 hybrid edition of CPhI – P-MEC conducted by CPhI Conference. The Online Conference & Networking is being held between 15th to 30th Nov 2021, while the In-Person event is being held between 24th to 26th Nov 2021 at India Expo Centre– Greater Noida, Delhi. In a bid to stay afloat towards increasing contemporary demand towards high qu...

Read More
news image

PHARMA SEES MORE POST-M&A REBRANDS THAN OTHER INDUSTRIES—AND IT DOES THEM BETTER, TOO

Fiercepharma | June 03, 2020

To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most prolific rebrander in Brand Finance’s recent research assessing the value of rebrands across 25 industries. It's also one of the most successful, with rebrands in pharma generating average returns of 13.8%, according to Brand Finance calculations. The main reason? Most acquired phar...

Read More
news image

Business Insights

HEALTH CANADA APPROVES IPSEN’S SOHONOS™ (PALOVAROTENE CAPSULES) AS THE FIRST APPROVED TREATMENT FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Ipsen | January 24, 2022

Ipsen announced the Health Canada approval of Sohonos, an oral selective retinoic-acid receptor gamma agonist indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva.1 Sohonos is approved for the treatment of patients with FOP for both chronic use, and for flare-ups, in these patient populations. This decision marks the first approval for Sohonos worldwide.<...

Read More
news image

COVID-19 BRINGS DIVISIONS ON HYDROXYCHLOROQUINE, REOPENING

Fiercepharma | May 19, 2020

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. As the pandemic plays out, political divisions have unfolded around hydroxychloroquine and reopening economies, for starters. At center stage last week was a House hearing over ousted Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright’s whistleblower complaint. While...

Read More

Resources

resource image

Research, PHARMACY MARKET

The filling equipment of choice for CDMOs

Video

resource image

Research, PHARMACY MARKET

Specific Pharma

Video

resource image

Research, PHARMACY MARKET

Ultimate Pharma Messaging Guidebook

Whitepaper

resource image

Research, PHARMACY MARKET

The filling equipment of choice for CDMOs

Video

resource image

Research, PHARMACY MARKET

Specific Pharma

Video

resource image

Research, PHARMACY MARKET

Ultimate Pharma Messaging Guidebook

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us